v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2023   406,387        
Beginning balance at Dec. 31, 2023 $ 661,021 $ 4,064 $ 1,986,899 $ (1,326,826) $ (2,298) $ (818)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (36,696)     (36,746)   50
Other comprehensive income (loss) (149)       (149)  
Exercise of stock options (in shares)   1,476        
Exercise of stock options 2,626 $ 15 2,611      
Vesting of restricted stock units (in shares)   1,860        
Vesting of restricted stock units 0 $ 17 (17)      
Shares withheld related to net share settlement (in shares)   (250)        
Shares withheld related to net share settlement (1,281) $ (2) (1,279)      
Issuance of common stock (in shares)   1,974        
Issuance of common stock 15,230 $ 20 15,210      
Stock-based compensation expense 35,116   35,116      
Ending balance, (in shares) at Jun. 30, 2024   411,447        
Ending balance at Jun. 30, 2024 675,867 $ 4,114 2,038,540 (1,363,572) (2,447) (768)
Beginning balance (in shares) at Mar. 31, 2024   410,843        
Beginning balance at Mar. 31, 2024 688,486 $ 4,108 2,020,803 (1,332,890) (2,747) (788)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (30,662)     (30,682)   20
Other comprehensive income (loss) 300       300  
Exercise of stock options (in shares)   42        
Exercise of stock options 171 $ 1 170      
Vesting of restricted stock units (in shares)   690        
Vesting of restricted stock units 0 $ 6 (6)      
Shares withheld related to net share settlement (in shares)   (128)        
Shares withheld related to net share settlement (635) $ (1) (634)      
Stock-based compensation expense 18,207   18,207      
Ending balance, (in shares) at Jun. 30, 2024   411,447        
Ending balance at Jun. 30, 2024 $ 675,867 $ 4,114 2,038,540 (1,363,572) (2,447) $ (768)
Beginning balance (in shares) at Dec. 31, 2024 412,194 412,194        
Beginning balance at Dec. 31, 2024 $ 470,952 $ 4,122 2,053,895 (1,586,977) (88)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (92,258)     (92,258)    
Other comprehensive income (loss) 875       875  
Exercise of stock options (in shares)   24        
Exercise of stock options 110   110      
Vesting of restricted stock units (in shares)   2,604        
Vesting of restricted stock units 0 $ 26 (26)      
Shares withheld related to net share settlement (in shares)   (539)        
Shares withheld related to net share settlement (2,851) $ (5) (2,846)      
Stock-based compensation expense $ 32,101   32,101      
Ending balance, (in shares) at Jun. 30, 2025 414,283 414,283        
Ending balance at Jun. 30, 2025 $ 408,929 $ 4,143 2,083,234 (1,679,235) 787  
Beginning balance (in shares) at Mar. 31, 2025   413,023        
Beginning balance at Mar. 31, 2025 500,254 $ 4,130 2,070,446 (1,574,865) 543  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (104,370)     (104,370)    
Other comprehensive income (loss) 244       244  
Exercise of stock options (in shares)   24        
Exercise of stock options 110   110      
Vesting of restricted stock units (in shares)   1,733        
Vesting of restricted stock units 0 $ 18 (18)      
Shares withheld related to net share settlement (in shares)   (497)        
Shares withheld related to net share settlement (2,690) $ (5) (2,685)      
Stock-based compensation expense $ 15,381   15,381      
Ending balance, (in shares) at Jun. 30, 2025 414,283 414,283        
Ending balance at Jun. 30, 2025 $ 408,929 $ 4,143 $ 2,083,234 $ (1,679,235) $ 787